Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia

This study has been withdrawn prior to enrollment.
(Trial closed just prior to study receiving Investigational Review Board approval)
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00538564
First received: October 1, 2007
Last updated: September 20, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)